PD
Point72 (DIFC) Portfolio holdings
AUM
$1.25B
1-Year Return
9.31%
This Quarter Return
+5.32%
1 Year Return
+9.31%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.25B
AUM Growth
+$216M
(+21%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
12.56%
Top 10 Holdings %
Top 10 Hldgs %
19.36%
Holding
1,672
New
551
Increased
173
Reduced
205
Closed
545
Top Buys
| 1 |
GE Aerospace
GE
|
+$22.9M |
| 2 |
Philip Morris
PM
|
+$22M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$21.3M |
| 4 |
CRH
CRH
|
+$19.2M |
| 5 |
Banco Bradesco
BBD
|
+$18.9M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$29.6M |
| 2 |
Cisco
CSCO
|
+$17.8M |
| 3 |
Qiagen
QGEN
|
+$14M |
| 4 |
Coca-Cola
KO
|
+$13.7M |
| 5 |
Steris
STE
|
+$13.4M |
Sector Composition
| 1 | Healthcare | 28.96% |
| 2 | Technology | 22.18% |
| 3 | Financials | 12.68% |
| 4 | Industrials | 10.17% |
| 5 | Consumer Discretionary | 7.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
876
Neumora Therapeutics
NMRA
$264M
| $821 | ﹤0.01% |
+1,119
| New | +$821 |
|
877
DHI Group
DHX
$143M
| $808 | ﹤0.01% |
272
-103
| -27% | -$306 |
|
878
Cooper-Standard Automotive
CPS
$685M
| $796 | ﹤0.01% |
37
-1,710
| -98% | -$36.8K |
|
879
Viridian Therapeutics
VRDN
$1.62B
| $761 | ﹤0.01% |
54
-4,719
| -99% | -$66.5K |
|
880
Candel Therapeutics
CADL
$266M
| $740 | ﹤0.01% |
+146
| New | +$740 |
|
881
Seer Inc
SEER
$117M
| $710 | ﹤0.01% |
332
-80
| -19% | -$171 |
|
882
Forrester Research
FORR
$188M
| $703 | ﹤0.01% |
+71
| New | +$703 |
|
883
Fractyl Health
GUTS
$70.1M
| $700 | ﹤0.01% |
+432
| New | +$700 |
|
884
Genelux
GNLX
$138M
| $695 | ﹤0.01% |
242
+94
| +64% | +$270 |
|
885
Renovaro
RENB
$47.8M
| $683 | ﹤0.01% |
+2,365
| New | +$683 |
|
886
Viemed Healthcare
VMD
$256M
| $649 | ﹤0.01% |
94
-1,190
| -93% | -$8.22K |
|
887
Sangamo Therapeutics
SGMO
$160M
| $646 | ﹤0.01% |
1,194
-23,374
| -95% | -$12.6K |
|
888
SelectQuote
SLQT
$339M
| $637 | ﹤0.01% |
+268
| New | +$637 |
|
889
Zura Bio
ZURA
$134M
| $631 | ﹤0.01% |
+601
| New | +$631 |
|
890
Outlook Therapeutics
OTLK
$44.4M
| $613 | ﹤0.01% |
+383
| New | +$613 |
|
891
Myomo
MYO
$33M
| $576 | ﹤0.01% |
267
+227
| +568% | +$490 |
|
892
Nautilus Biotechnolgy
NAUT
$89.3M
| $572 | ﹤0.01% |
+789
| New | +$572 |
|
893
Orange County Bancorp
OBT
$347M
| $568 | ﹤0.01% |
+22
| New | +$568 |
|
894
Sera Prognostics
SERA
$117M
| $566 | ﹤0.01% |
+204
| New | +$566 |
|
|
TEAD
895
Teads Holding Co. Common Stock
TEAD
$149M
| $563 | ﹤0.01% |
227
-482
| -68% | -$1.2K |
|
896
LanzaTech
LNZA
$44.7M
| $523 | ﹤0.01% |
+19
| New | +$523 |
|
|
CLYM
897
Climb Bio, Inc. Common Stock
CLYM
$161M
| $522 | ﹤0.01% |
+421
| New | +$522 |
|
898
Universal Electronics
UEIC
$62.8M
| $503 | ﹤0.01% |
76
| – | – |
|
|
YSG
899
Yatsen Holding
YSG
$959M
| $501 | ﹤0.01% |
+52
| New | +$501 |
|
900
Adverum Biotechnologies
ADVM
$69.5M
| $484 | ﹤0.01% |
+225
| New | +$484 |
|